Acne vulgaris in adolescents aged 12-17 years
Conditions
Interventions
Experimental group:Needle clearing + 30% supramolecular salicylic acid treatment
Sponsors
Chengdu Second People's Hospital
Eligibility
Sex/Gender
All
Age
12 Years to 17 Years
Inclusion criteria
Inclusion criteria: 1) Male and female, age 12-17 years old; 2) Diagnosed with acne vulgaris, Pillsbury International Improved Classification of facial acne ?-? (see Annex 1); 3) The informed consent must be signed by both the subject and his legal guardian.
Exclusion criteria
Exclusion criteria: 1) have another skin condition that may aggravate the condition, or the investigator believes that this condition may affect the judgment of the test results; 2) Allergic to the test product or hypersensitive physique, female pregnant patients; 3) Patients who took oral antibiotics, glucocorticoids, spironolactones and other anti-androgens and other acne drugs within 4 weeks before the trial; Or patients who have used physical therapy for acne, such as photodynamic, red and blue light treatment; Or patients treated with salicylic acid and hydroxy acid; Or have used other topical acne medications within 2 weeks; 4) Oral retinoic acid within 2 months before the trial (6 months for avitaric acid); 5) Patients with a history of facial injection or surgery 2 months before the trial; 6) Patients with immunodeficiency diseases;(YNMT)·
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Skin loss rate;GAGS score; | — |
Secondary
| Measure | Time frame |
|---|---|
| Researcher satisfaction;Patient symptom evaluation;Patient efficacy evaluation;Patient satisfaction evaluation; | — |
Countries
China
Contacts
Public ContactWa Qingbiao
Chengdu Second People's Hospital
Outcome results
None listed